Literature DB >> 17516013

Prevalence of mental disorders based on general population surveys.

Harald Baumeister1, Martin Härter.   

Abstract

OBJECTIVE: In the last two decades, a multitude of investigations into the frequency of mental disorders in the population have emerged, making it difficult to keep track of recent findings and tasks. Building on a historical review, the present study provides a comprehensive overview of knowledge about the prevalence of mental disorders.
METHOD: The review is based on current national surveys with comparable methodology. Study selection, based on a consecutive literature search through August 2005, led to the inclusion of Australian, German, Dutch and US-American (NCS; NCS-R) surveys of mental disorders in the general population.
RESULTS: A considerable proportion of the population is found to have a mental disorder. The most frequent disorders within the preceding 12 months are mood disorders (6.6-11.9%) and anxiety disorders (5.6-18.1%). Substance disorders (3.8-11.3%) and somatoform disorders (11.0%) are also very frequent. The prevalence rates presented in each survey are dependent on the specific disorders included and the classification system underlying them. Important risk factors are being female, being unmarried, being unemployed and having a low social status.
CONCLUSIONS: Knowledge about mental disorders in the general population can contribute to bringing about considerable improvement in the treatment of mental disorders. In addition to available knowledge, however, there is a continued need to address existing challenges from both a methodological and content-related perspective, e.g. the lack of or inadequate inclusion of specific disorders, the lack of prevalence rates of mental disorders in childhood and adolescence, and the as yet only rare inclusion of personality disorders.

Entities:  

Mesh:

Year:  2007        PMID: 17516013     DOI: 10.1007/s00127-007-0204-1

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.519


  74 in total

1.  Epidemiologic differences in drug dependence--a US-UK cross-national comparison.

Authors:  Carolyn D M Furr-Holden; James C Anthony
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2003-04       Impact factor: 4.328

2.  Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule.

Authors:  H G Hwu; E K Yeh; L Y Chang
Journal:  Acta Psychiatr Scand       Date:  1989-02       Impact factor: 6.392

3.  The 12-month prevalence and characteristics of major depressive episode in a representative nationwide sample of adolescents and young adults.

Authors:  L Haarasilta; M Marttunen; J Kaprio; H Aro
Journal:  Psychol Med       Date:  2001-10       Impact factor: 7.723

4.  The National Psychiatric Morbidity surveys of Great Britain--strategy and methods.

Authors:  R Jenkins; P Bebbington; T Brugha; M Farrell; B Gill; G Lewis; H Meltzer; M Petticrew
Journal:  Psychol Med       Date:  1997-07       Impact factor: 7.723

5.  An open trial of paroxetine for the "offensive subtype" of taijin kyofusho and social anxiety disorder.

Authors:  Toshihiko Nagata; Irene van Vliet; Hisashi Yamada; Kouhei Kataoka; Toshiya Iketani; Nobuo Kiriike
Journal:  Depress Anxiety       Date:  2006       Impact factor: 6.505

6.  Trends in service use and treatment for mental disorders in adults throughout Great Britain.

Authors:  Traolach S Brugha; Paul E Bebbington; Nicola Singleton; David Melzer; Rachel Jenkins; Glyn Lewis; Michael Farrell; Dinesh Bhugra; Alison Lee; Howard Meltzer
Journal:  Br J Psychiatry       Date:  2004-11       Impact factor: 9.319

7.  Epidemiology of mood disorders: a community survey in Florence.

Authors:  C Faravelli; B Guerrini Degl'Innocenti; L Aiazzi; G Incerpi; S Pallanti
Journal:  J Affect Disord       Date:  1990-10       Impact factor: 4.839

8.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01

9.  The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design.

Authors:  R V Bijl; G van Zessen; A Ravelli; C de Rijk; Y Langendoen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-12       Impact factor: 4.328

Review 10.  Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review.

Authors:  H U Wittchen
Journal:  J Psychiatr Res       Date:  1994 Jan-Feb       Impact factor: 4.791

View more
  47 in total

1.  Depressive symptoms in the Belgian population: disentangling age and cohort effects.

Authors:  Marie-Christine Brault; Bart Meuleman; Piet Bracke
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-06-01       Impact factor: 4.328

2.  Prevalence, trends, correlates and treatment of depression in Chile in 2003 to 2010.

Authors:  Niina Markkula; Pedro Zitko; Sebastián Peña; Paula Margozzini; Pedro Retamal C
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-02-14       Impact factor: 4.328

3.  Self-reported depression in first-year nursing students in relation to socio-demographic and educational factors: a nationwide cross-sectional study in Sweden.

Authors:  Anna Christensson; Marjan Vaez; Paul W Dickman; Bo Runeson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-03-07       Impact factor: 4.328

4.  Dropout from outpatient mental health care: results from the Israel National Health Survey.

Authors:  Yaacov Lerner; Daphna Levinson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-06-12       Impact factor: 4.328

5.  The Patient Assessment of Chronic Illness Care questionnaire: evaluation in patients with mental disorders in primary care.

Authors:  J Gensichen; A Serras; M A Paulitsch; T Rosemann; J König; F M Gerlach; J J Petersen
Journal:  Community Ment Health J       Date:  2010-08-24

6.  The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders.

Authors:  Parichehr Hassanzadeh; Elham Arbabi; Fatemeh Atyabi; Rassoul Dinarvand
Journal:  Psychopharmacology (Berl)       Date:  2016-01-18       Impact factor: 4.530

7.  Relationship quality and levels of depression and anxiety in a large population-based survey.

Authors:  Liana S Leach; Peter Butterworth; Sarah C Olesen; Andrew Mackinnon
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-08-09       Impact factor: 4.328

8.  Antidepressant effects of resveratrol in an animal model of depression.

Authors:  Laura L Hurley; Luli Akinfiresoye; Olubukola Kalejaiye; Yousef Tizabi
Journal:  Behav Brain Res       Date:  2014-04-06       Impact factor: 3.332

Review 9.  Healthcare costs in patients with diabetes mellitus and comorbid mental disorders--a systematic review.

Authors:  N Hutter; A Schnurr; H Baumeister
Journal:  Diabetologia       Date:  2010-08-11       Impact factor: 10.122

10.  The Dresden Predictor Study of anxiety and depression: objectives, design, and methods.

Authors:  Julia Trumpf; Noortje Vriends; Andrea H Meyer; Eni S Becker; Simon-Peter Neumer; Jürgen Margraf
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-09       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.